*Yu-Ping Liu1,2, Yi-Fang Chuang3,4, Yi-Chien Liu5, Yan-Siang Huang6, Sui-Hing Yan6, Chia-Ju Chou5, Yao-Chia Shih1, Yen-Ling Chiu1,7, Yang-Teng Fan1
(1. Graduate Institute of Medicine, Yuan Ze University, Taoyuan, Taiwan, 2. Medical Imaging Division, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 3. Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan, 4. Department of Psychiatry, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 5. Department of Neurology, Cardinal Tien Hospital, New Taipei City, Taiwan, 6. Department of Neurology, Far Eastern Memorial Hospital, New Taipei City, Taiwan, 7. Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City, Taiwan)
Keywords:Mild cognitive impairment, Cognitive decline, Neuroimaging, COVID-19